Subpathway Analysis based on Signaling-Pathway Impact Analysis of Signaling Pathway

Pathway analysis is a common approach to gain insight from biological experiments. Signaling-pathway impact analysis (SPIA) is one such method and combines both the classical enrichment analysis and the actual perturbation on a given pathway. Because this method focuses on a single pathway, its resolution generally is not very high because the differentially expressed genes may be enriched in a local region of the pathway. In the present work, to identify cancer-related pathways, we incorporated a recent subpathway analysis method into the SPIA method to form the “sub-SPIA method.” The original subpathway analysis uses the k-clique structure to define a subpathway. However, it is not sufficiently flexible to capture subpathways with complex structure and usually results in many overlapping subpathways. We therefore propose using the minimal-spanning-tree structure to find a subpathway. We apply this approach to colorectal cancer and lung cancer datasets, and our results show that sub-SPIA can identify many significant pathways associated with each specific cancer that other methods miss. Based on the entire pathway network in the Kyoto Encyclopedia of Genes and Genomes, we find that the pathways identified by sub-SPIA not only have the largest average degree, but also are more closely connected than those identified by other methods. This result suggests that the abnormality signal propagating through them might be responsible for the specific cancer or disease.

[1]  W. Qu,et al.  Interleukin 7 signaling prevents apoptosis by regulating bcl-2 and bax via the p53 pathway in human non-small cell lung cancer cells. , 2014, International journal of clinical and experimental pathology.

[2]  K. Ho,et al.  A Susceptibility Gene Set for Early Onset Colorectal Cancer That Integrates Diverse Signaling Pathways: Implication for Tumorigenesis , 2007, Clinical Cancer Research.

[3]  Gabriele Sales,et al.  graphite - a Bioconductor package to convert pathway topology to gene network , 2012, BMC Bioinformatics.

[4]  Chunquan Li,et al.  A novel dysregulated pathway-identification analysis based on global influence of within-pathway effects and crosstalk between pathways , 2015, Journal of The Royal Society Interface.

[5]  C. Ahn,et al.  A Splicing Variant of NME1 Negatively Regulates NF-κB Signaling and Inhibits Cancer Metastasis by Interacting with IKKβ* , 2014, The Journal of Biological Chemistry.

[6]  M. Spitz,et al.  Genetic Variants in Cell Cycle Control Pathway Confer Susceptibility to Lung Cancer , 2007, Clinical Cancer Research.

[7]  Pooja Mittal,et al.  A novel signaling pathway impact analysis , 2009, Bioinform..

[8]  Li‐jun Wu,et al.  Silencing of Rac1 modifies lung cancer cell migration, invasion and actin cytoskeleton rearrangements and enhances chemosensitivity to antitumor drugs. , 2011, International journal of molecular medicine.

[9]  Y. Benjamini,et al.  THE CONTROL OF THE FALSE DISCOVERY RATE IN MULTIPLE TESTING UNDER DEPENDENCY , 2001 .

[10]  K. Nan,et al.  SDF-1/CXCR4 promotes epithelial-mesenchymal transition and progression of colorectal cancer by activation of the Wnt/β-catenin signaling pathway. , 2014, Cancer letters.

[11]  P. Khatri,et al.  Global functional profiling of gene expression ? ? This work was funded in part by a Sun Microsystem , 2003 .

[12]  M. Ptito,et al.  Concerted Action of CB1 Cannabinoid Receptor and Deleted in Colorectal Cancer in Axon Guidance , 2011, The Journal of Neuroscience.

[13]  B. Vincenzi,et al.  Cell cycle alterations and lung cancer. , 2006, Histology and histopathology.

[14]  M. Qadan,et al.  The actin-cytoskeleton pathway and its potential role in inflammatory bowel disease-associated human colorectal cancer. , 2010, Genetic testing and molecular biomarkers.

[15]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.

[16]  K. Straif,et al.  A review of human carcinogens--Part B: biological agents. , 2009, The Lancet. Oncology.

[17]  Nathalia Amado,et al.  Flavonoids and Wnt/β-Catenin Signaling: Potential Role in Colorectal Cancer Therapies , 2014, International journal of molecular sciences.

[18]  T. Hoey,et al.  NOTCH3 signaling regulates MUSASHI-1 expression in metastatic colorectal cancer cells. , 2014, Cancer research.

[19]  Qi Zheng,et al.  GOEAST: a web-based software toolkit for Gene Ontology enrichment analysis , 2008, Nucleic Acids Res..

[20]  V. Golubovskaya,et al.  Focal adhesion kinase autophosphorylation inhibition decreases colon cancer cell growth and enhances the efficacy of chemotherapy , 2013, Cancer biology & therapy.

[21]  Christian Baumgartner,et al.  Genetic network and gene set enrichment analysis to identify biomarkers related to cigarette smoking and lung cancer. , 2013, Cancer treatment reviews.

[22]  Y. Dobashi Cell cycle regulation and its aberrations in human lung carcinoma , 2005, Pathology international.

[23]  R. Roskoski The ErbB/HER family of protein-tyrosine kinases and cancer. , 2014, Pharmacological research.

[24]  S. So,et al.  Frequent inactivation of axon guidance molecule RGMA in human colon cancer through genetic and epigenetic mechanisms. , 2009, Gastroenterology.

[25]  Chunquan Li,et al.  The Implications of Relationships between Human Diseases and Metabolic Subpathways , 2011, PloS one.

[26]  A Coldman,et al.  Evaluation of immunohistochemical markers in non‐small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers , 2004, The Journal of pathology.

[27]  Yong Lin,et al.  NF-kappaB in lung cancer, a carcinogenesis mediator and a prevention and therapy target. , 2011, Frontiers in bioscience.

[28]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[29]  B. Simon,et al.  A Gene Expression and Pre-mRNA Splicing Signature That Marks the Adenoma-Adenocarcinoma Progression in Colorectal Cancer , 2014, PloS one.

[30]  T. Miyazaki,et al.  Short-term intravenous antimicrobial prophylaxis in combination with preoperative oral antibiotics on surgical site infection and methicillin-resistant Staphylococcus aureus infection in elective colon cancer surgery: Results of a prospective randomized trial , 2009, Surgery Today.

[31]  M. V. Van Dyke,et al.  Constitutive and inducible nuclear factor-kappaB in immortalized normal human bronchial epithelial and non-small cell lung cancer cell lines. , 2007, Cancer letters.

[32]  Chun Xing Li,et al.  Sorbitol induces apoptosis of human colorectal cancer cells via p38 MAPK signal transduction , 2014, Oncology letters.

[33]  M. Cooke,et al.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate , 2010, Nature Reviews Immunology.

[34]  M. Ilyas,et al.  Nuclear expression of phosphorylated focal adhesion kinase is associated with poor prognosis in human colorectal cancer. , 2014, Anticancer research.

[35]  A. Sadikot,et al.  Critical Roles for the Netrin Receptor Deleted in Colorectal Cancer in Dopaminergic Neuronal Precursor Migration, Axon Guidance, and Axon Arborization , 2010, Neuroscience.

[36]  L. Ylagan,et al.  The Prognostic Significance of Focal Adhesion Kinase Expression in Stage I Non–Small-Cell Lung Cancer , 2014, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[37]  Jingyu Yang,et al.  Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling , 2013, British Journal of Cancer.

[38]  Sandrine Dudoit,et al.  More power via graph-structured tests for differential expression of gene networks , 2012, 1206.6980.

[39]  I. Kawase,et al.  Comparison of the clinical courses and chemotherapy outcomes in metastatic colorectal cancer patients with and without active Mycobacterium tuberculosis or Mycobacterium kansasii infection: a retrospective study , 2014, BMC Cancer.

[40]  Monica Chiogna,et al.  Along signal paths: an empirical gene set approach exploiting pathway topology , 2012, Nucleic acids research.

[41]  David Haussler,et al.  Inference of patient-specific pathway activities from multi-dimensional cancer genomics data using PARADIGM , 2010, Bioinform..

[42]  S. Sang,et al.  Induction of Lung Cancer Cell Apoptosis through a p53 Pathway by [6]-Shogaol and Its Cysteine-Conjugated Metabolite M2 , 2014, Journal of agricultural and food chemistry.

[43]  Atul J. Butte,et al.  Ten Years of Pathway Analysis: Current Approaches and Outstanding Challenges , 2012, PLoS Comput. Biol..

[44]  N. Yoo,et al.  Frameshift mutations of axon guidance genes ROBO1 and ROBO2 in gastric and colorectal cancers with microsatellite instability , 2013, Pathology.

[45]  F. Zheng,et al.  p38α MAPK-mediated induction and interaction of FOXO3a and p53 contribute to the inhibited-growth and induced-apoptosis of human lung adenocarcinoma cells by berberine , 2014, Journal of experimental & clinical cancer research : CR.

[46]  F. Marincola,et al.  Epstein–Barr virus microRNAs and lung cancer , 2011, British Journal of Cancer.

[47]  A. Harris,et al.  Notch3 signalling promotes tumour growth in colorectal cancer , 2011, The Journal of pathology.

[48]  Jun Zhou,et al.  Function and mode of action of cytohesins in the epidermal growth factor pathway in colorectal cancer cells , 2012, Oncology letters.

[49]  Raphael Kopan,et al.  The Notch pathway: democracy and aristocracy in the selection of cell fate , 1996, Current Opinion in Neurobiology.

[50]  Thomas Lengauer,et al.  Statistical Applications in Genetics and Molecular Biology Calculating the Statistical Significance of Changes in Pathway Activity From Gene Expression Data , 2011 .

[51]  Mei Liu,et al.  Inactivation of the Fanconi anemia/BRCA pathway in lung and oral cancers: implications for treatment and survival , 2004, Oncogene.

[52]  Tom D. Bunney,et al.  Phosphoinositide signalling in cancer: beyond PI3K and PTEN , 2010, Nature Reviews Cancer.

[53]  B. Osborne,et al.  Notch signaling as a therapeutic target in cancer: a new approach to the development of cell fate modifying agents , 2003, Oncogene.

[54]  Jian-Hong Wu,et al.  Proliferation of Colorectal Cancer Is Promoted by Two Signaling Transduction Expression Patterns: ErbB2/ErbB3/AKT and MET/ErbB3/MAPK , 2013, PloS one.

[55]  Joaquín Dopazo,et al.  Understanding disease mechanisms with models of signaling pathway activities , 2014, BMC Systems Biology.

[56]  Colin N. Dewey,et al.  Initial sequencing and comparative analysis of the mouse genome. , 2002 .

[57]  A. Sweet-Cordero,et al.  Differential effects of oncogenic K-Ras and N-Ras on proliferation, differentiation and tumor progression in the colon , 2008, Nature Genetics.

[58]  O. Tawfik,et al.  Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner. , 2014, Carcinogenesis.

[59]  K. Kono,et al.  Expression of signal transducing T‐cell receptor ζ molecules after adoptive immunotherapy in patients with gastric and colon cancer , 1998, International journal of cancer.

[60]  Wafik S El-Deiry,et al.  TRAIL and apoptosis induction by TNF-family death receptors , 2003, Oncogene.

[61]  E. Małusecka,et al.  Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study. , 1999, Folia histochemica et cytobiologica.

[62]  Lin Zhu,et al.  Differential BCCIP gene expression in primary human ovarian cancer, renal cell carcinoma and colorectal cancer tissues. , 2013, International journal of oncology.

[63]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[64]  P. Khatri,et al.  Global functional profiling of gene expression. , 2003, Genomics.

[65]  Mouse Genome Sequencing Consortium Initial sequencing and comparative analysis of the mouse genome , 2002, Nature.

[66]  Yuan Wang,et al.  Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[67]  Louis Vermeulen,et al.  Wnt activity defines colon cancer stem cells and is regulated by the microenvironment , 2010, Nature Cell Biology.

[68]  Helen X. Chen,et al.  Multi-drug inhibition of the HER pathway in metastatic colorectal cancer: Results of a phase I study of pertuzumab plus cetuximab in cetuximab-refractory patients , 2014, Investigational New Drugs.

[69]  I. Abdulkader,et al.  Cell-cycle-associated markers and clinical outcome in human epithelial cancers: a tissue microarray study. , 2005, Oncology Report.

[70]  S. Morini,et al.  The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies , 2011, Journal of carcinogenesis.

[71]  Yan Wang,et al.  Characterizing the Network of Drugs and Their Affected Metabolic Subpathways , 2012, PloS one.

[72]  D. Karunagaran,et al.  Emodin suppresses Wnt signaling in human colorectal cancer cells SW480 and SW620. , 2014, European Journal of Pharmacology.

[73]  Ming-wu Chen,et al.  MYLK and MYL9 expression in non-small cell lung cancer identified by bioinformatics analysis of public expression data , 2014, Tumor Biology.

[74]  Julia B. Cordero,et al.  Reduced LIMK2 expression in colorectal cancer reflects its role in limiting stem cell proliferation , 2013, Gut.

[75]  M. Daly,et al.  PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes , 2003, Nature Genetics.

[76]  J. Bartlett,et al.  Extra‐Intestinal Manifestations of Salmonella Infections , 1987, Medicine.

[77]  C. Simone,et al.  p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance. , 2014, World journal of gastroenterology.

[78]  Vassilis G Gorgoulis,et al.  Dual function of p38α MAPK in colon cancer: suppression of colitis-associated tumor initiation but requirement for cancer cell survival. , 2014, Cancer cell.

[79]  P. Khatri,et al.  Profiling gene expression using onto-express. , 2002, Genomics.

[80]  Yong Cai,et al.  Correlation of low expression of hMOF with clinicopathological features of colorectal carcinoma, gastric cancer and renal cell carcinoma. , 2014, International journal of oncology.

[81]  G. Samonis,et al.  Salmonella enterica Pneumonia in a Patient with Lung Cancer , 2003, Journal of Clinical Microbiology.

[82]  M. Unlu,et al.  Primary lung cancer coexisting with active pulmonary tuberculosis. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[83]  Richard D Neal,et al.  The diagnostic value of symptoms for colorectal cancer in primary care: a systematic review. , 2011, The British journal of general practice : the journal of the Royal College of General Practitioners.

[84]  L. Havel,et al.  Vimentin regulates lung cancer cell adhesion through a VAV2-Rac1 pathway to control focal adhesion kinase activity , 2014, Oncogene.

[85]  S. Wacholder,et al.  Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.

[86]  Hui-Jen Chang,et al.  CDC25A, VAV1, TP73, BRCA1 and ZAP70 gene overexpression correlates with radiation response in colorectal cancer. , 2011, Oncology reports.

[87]  H. Modjtahedi,et al.  Prognostic significance and targeting of HER family in colorectal cancer. , 2013, Frontiers in bioscience.

[88]  Chunquan Li,et al.  SubpathwayMiner: a software package for flexible identification of pathways , 2009, Nucleic acids research.